Register
Login:
Share:
Email Facebook Twitter

RNS VIDEO: Reabold Resources #RBD raise £6 million and take stake in Danube Petroleum Watch here

EXCLUSIVE: HemoGenyx are creating blood cancer treatments with US$9 billion market potential


Mediclinic International Share Chat (MDC)



Share Price: 609.00Bid: 608.00Ask: 609.00Change: 0.00 (0.00%)No Movement on Mediclinic
Spread: 1.00Spread as %: 0.16%Open: 615.50High: 616.00Low: 597.50Yesterday’s Close: 609.00


Share Discussion for Mediclinic International


Thread View

Please login or register to post a message on Share Chat.

Posts per page:


denby69
Posts: 566
Off Topic
Opinion:No Opinion
Price:594.50
what
25 Oct '17
What the hell is going on with this share ????
 
QueenElvis
Posts: 9,566
Off Topic
Opinion:No Opinion
Price:821.00
RE: That's the rns news
30 Apr '17
Was a good Easter! Had a lean time on the isle of Coll food wise but plenty of smiles!
Robert34
Posts: 866
Off Topic
Opinion:No Opinion
Price:864.50
RE: That's the rns news
27 Apr '17
That is good news.
QueenElvis
Posts: 9,566
Off Topic
Opinion:No Opinion
Price:726.50
That's the rns news
10 Apr '17
I was waiting for. Good stuff here.
QueenElvis
Posts: 9,566
Off Topic
Opinion:No Opinion
Price:696.00
Should I stay or should I go
7 Apr '17
Hopefully a lot more legs in this.
QueenElvis
Posts: 9,566
Off Topic
Opinion:No Opinion
Price:679.50
I bought
6 Apr '17
hammered enough. See what happens. Good luck anybody else alive who might be invested.




Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk






Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.